Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 157

1.

Significance of benign endometrial cells in papanicolaou tests from women aged >or=40 years.

Thrall MJ, Kjeldahl KS, Savik K, Gulbahce HE, Pambuccian SE.

Cancer. 2005 Aug 25;105(4):207-16.

4.

Significance of benign endometrial cells in Pap smears from postmenopausal women.

Wu HH, Schuetz MJ 3rd, Cramer H.

J Reprod Med. 2001 Sep;46(9):795-8.

PMID:
11584479
5.

Cytologically benign endometrial cells in the papanicolaou smears of postmenopausal women.

Chang A, Sandweiss L, Bose S.

Gynecol Oncol. 2001 Jan;80(1):37-43.

PMID:
11136567
6.

Clinical relevance of benign endometrial cells in postmenopausal women.

Ashfaq R, Sharma S, Dulley T, Saboorian MH, Siddiqui MT, Warner C.

Diagn Cytopathol. 2001 Oct;25(4):235-8.

PMID:
11599107
7.

Normal endometrial cells in Papanicolaou smears: prevalence in women with and without endometrial disease.

Gomez-Fernandez CR, Ganjei-Azar P, Behshid K, Averette HE, Nadji M.

Obstet Gynecol. 2000 Dec;96(6):874-8.

PMID:
11084170
8.

Rate of endometrial adenocarcinoma in women screened before and after implementation of the Bethesda 2001 reporting system.

Thrall M, Kjeldahl K, Savik K, Gulbahce HE, Pambuccian SE.

Acta Cytol. 2008 Jan-Feb;52(1):1-7.

PMID:
18323269
9.

In Papanicolaou smears, benign appearing endometrial cells bear no significance in predicting uterine endometrial adenocarcinomas.

Moatamed NA, Le LT, Levin MR, Govind R, Apple SK.

Diagn Cytopathol. 2013 Apr;41(4):335-41. doi: 10.1002/dc.21863.

PMID:
22102567
10.

Normal-Appearing Endometrial Cells in Pap Tests of Women Aged Forty Years or Older and Cytohistological Correlates.

Izadi-Mood N, Sarmadi S, Sanii S, Sadidi H.

Acta Cytol. 2015;59(2):175-9. doi: 10.1159/000381326.

PMID:
25924690
12.

Significant increase of benign endometrial cells on Papanicolaou smears in women using hormone replacement therapy.

Mount SL, Wegner EK, Eltabbakh GH, Olmstead JI, Drejet AE.

Obstet Gynecol. 2002 Sep;100(3):445-50.

PMID:
12220762
13.
14.

Clinical implications of atypical glandular cells of undetermined significance, favor endometrial origin.

Chhieng DC, Elgert P, Cohen JM, Cangiarella JF.

Cancer. 2001 Dec 25;93(6):351-6.

PMID:
11748574
15.

Clinical significance of a cytologic diagnosis of atypical glandular cells, favor endometrial origin, in Pap smears.

Saad RS, Takei H, Liu YL, Silverman JE, Lipscomb JT, Ruiz B.

Acta Cytol. 2006 Jan-Feb;50(1):48-54.

PMID:
16514840
16.

Correlation between endometrial cells on Papanicolaou smear and endometrial carcinoma.

Kerpsack JT, Finan MA, Kline RC.

South Med J. 1998 Aug;91(8):749-52.

PMID:
9715221
17.

Value of histiocyte detection in Pap smears for predicting endometrial pathology. An institutional experience.

Nassar A, Fleisher SR, Nasuti JF.

Acta Cytol. 2003 Sep-Oct;47(5):762-7.

PMID:
14526675
18.
19.

Reporting endometrial cells in women 40 years and older: assessing the clinical usefulness of Bethesda 2001.

Simsir A, Carter W, Elgert P, Cangiarella J.

Am J Clin Pathol. 2005 Apr;123(4):571-5.

PMID:
15743742
20.

Rate of pathology from atypical glandular cell Pap tests classified by the Bethesda 2001 nomenclature.

DeSimone CP, Day ME, Tovar MM, Dietrich CS 3rd, Eastham ML, Modesitt SC.

Obstet Gynecol. 2006 Jun;107(6):1285-91.

PMID:
16738153

Supplemental Content

Support Center